Analysis of the effect of buprenorphine transdermal patch on patients with moderate to severe chronic pain

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2100047449

Enrollment

Unknown

Registered

2021-06-18

Start date

2021-09-01

Completion date

Unknown

Last updated

2022-02-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic pain

Interventions

Case series:None

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1.A non-cancer pain patient who received buprenorphine transdermal patch treatment for the first time in the pain clinic; 2.Age> 18 years old; 3.Pain lasting more than one month; 4.NRS pain score> 4; 5.This patient can complete the study period independently or with the help of family members Assessment of own pain status.

Exclusion criteria

Exclusion criteria: 1.Patients with severe organ dysfunction; 2.Patients who are unwilling to accept the observational study; 3.Patients with neurological or psychiatric diseases and unable to complete the pain assessment; 4.Patients with a history of drug abuse or alcoholism; patients who are resistant to opioids; 5.Patients who are allergic to norphine or transdermal patch preparations; 6.Unexplained pain; 7.Patients with contraindications listed on other drug instructions.

Design outcomes

Primary

Measure	Time frame
Pain score;	—

Countries

China

Contacts

Public ContactYan Min

The Second Affiliated Hospital of Zhejiang University

zryanmin@zju.edu.cn+86 13757118632

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026